Muenchen
Germany
15
2018-09-06
The entities that hold a legal rights for patent applications filed by inventor Hasmann Max:
Max Hasmann from Muenchen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY
#2 | 2017-08-24TUMOR THERAPY WITH AN ANTIBODY FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND AN ANTIBODY FOR HUMAN EPITHELIAL GROWTH FACTOR RECEPTOR TYPE 2
#3 | 2016-06-09COMBINATION THERAPY OF ANTI-HER3 ANTIBODIES
#4 | 2015-10-08Tumor Therapy with an Antibody for Vascular Endothelial Growth Factor and an Antibody for Human Epithelial Growth Factor Receptor Type 2
#5 | 2015-08-27TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY
#6 | 2014-08-14Combination therapy of anti-HER3 antibodies
#7 | 2013-12-05Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label
#8 | 2013-07-18TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY
#9 | 2011-09-15TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY
#10 | 2011-03-17Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
#11 | 2011-02-03Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label
#12 | 2010-11-11TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY
#13 | 2008-05-01TUMOR THERAPY WITH A COMBINATION OF ANTI-HER2 ANTIBODIES
#14 | 2008-02-28TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY
#15 | 2007-09-27Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
343950 ⎘